Drug intelligence / Profile preview

Sanchi-Tongshu Capsule

Development stage
Phase 1
Lead developer
Chengdu HuaSun Group
Modality
Small Molecules
Administration
Oral
01

Overview

Sanchi-Tongshu is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by the Pharmaceutical Factory of Chengdu HuaSun Group Inc., Ltd. The drug is composed of Panax notoginseng triol saponins (PTS), with the primary bioactive components being ginsenoside Rg1, ginsenoside Re, and notoginsenoside R1. It is primarily indicated for the treatment of ischemic stroke and cardiovascular diseases, functioning by targeting glycoprotein 1b alpha (GP1BA) to reduce platelet aggregation and adhesion. This mechanism provides cerebral protective effects in cases of cerebral ischemia and infarction. Marketed in China since 2003, Sanchi-Tongshu is available in both standard and enteric-coated capsule forms and has been investigated for the treatment of aural vertigo and potential registration in the European market.

Brand names
Sanchi-Tongshu CapsuleSanqi Tongshu Capsule
Other names
Panax notoginseng triol saponins
02

Targets

GP1BA (Platelet glycoprotein ib alpha chain)

Beyond the preview

Go deeper on Sanchi-Tongshu Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanchi-Tongshu Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call